Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure

World Journal of Gastroenterology

Volumn 17, Issue 11, 2011, Pages 1457-1461

  Dabos, Konstantinos J ^a,b   Whalen, Henry R ^a   Newsome, Philip N ^a   Parkinson, John A ^a   Henderson, Neil C ^a   Sadler, Ian H ^a   Hayes, Peter C ^a   Plevris, John N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

Aromatic amino acids; Branch chain amino acids; Lactate; Pyruvate

Indexed keywords

ALANINE; GLYCINE; ISOLEUCINE; LACTIC ACID; PARACETAMOL; PHENYLALANINE; PYRUVIC ACID; THREONINE; TYROSINE; VALINE;

ACUTE LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CITRIC ACID CYCLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLYCOLYSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE; SWINE;

EID: 79955939065     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i11.1457     Document Type: Article

References (26)

1. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401-1415
2. Plevris JN, Schina M, Hayes PC. Review article: the management of acute liver failure. Aliment Pharmacol Ther 1998; 12: 405-418
3. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminopheninduced acute liver failure. Hepatology 1998; 27: 1050-1055
4. Arai K, Lee K, Berthiaume F, Tompkins RG, Yarmush ML. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology 2001; 34: 360-371
5. Yokoyama T, Banta S, Berthiaume F, Nagrath D, Tompkins RG, Yarmush ML. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metab Eng 2005; 7: 88-103
6. Carvalho RA, Jones JG, McGuirk C, Sherry AD, Malloy CR. Hepatic gluconeogenesis and Krebs cycle fluxes in a CCl4 model of acute liver failure. NMR Biomed 2002; 15: 45-51
7. Newsome PN, Henderson NC, Nelson LJ, Dabos C, Filippi C, Bellamy C, Howie F, Clutton RE, King T, Lee A, Hayes PC, Plevris JN. Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure. BMC Gastroenterol 2010; 10: 34
8. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109-119
9. Blantz RC. Acetaminophen: acute and chronic effects on renal function. Am J Kidney Dis 1996; 28: S3-S6
10. Krähenbühl S, Reichen J. Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis. J Hepatol 1993; 19: 64-70
11. Petrides AS, Schulze-Berge D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993; 18: 284-291
12. Petersen KF, Krssak M, Navarro V, Chandramouli V, Hundal R, Schumann WC, Landau BR, Shulman GI. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol 1999; 276: E529-E535
13. Lindon JC, Nicholson JK, Everet JR. NMR spectroscopy of biofluids. Ann Reports NMR Spectroscopy 1999; 38: 1-87
14. Tréhout D, Desille M, Doan BT, Mahler S, Frémond B, Mallédant Y, Campion JP, Desbois J, Beloeil JC, de Certaines J, Clément B. Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver. NMR Biomed 2002; 15: 393-403
15. Dabos KJ, Newsome PN, Parkinson JA, Mohammed HH, Sadler IH, Plevris JN, Hayes PC. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 2004; 77: 200-205
16. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study. Lancet 2002; 359: 558-563
17. Shito M, Balis UJ, Tompkins RG, Yarmush ML, Toner M. A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha. Dig Dis Sci 2001; 46: 1700-1708
18. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80: 77-91
19. Morgan MY, Blei A, Grüngreiff K, Jalan R, Kircheis G, Marchesini G, Riggio O, Weissenborn K. The treatment of hepatic encephalopathy. Metab Brain Dis 2007; 22: 389-405
20. Battezzati A, Caumo A, Fattorini A, Sereni LP, Coppa J, Romito R, Ammatuna M, Regalia E, Mazzaferro V, Luzi L. Amino acid kinetics during the anhepatic phase of liver transplantation. Diabetes 2002; 51: 1690-1698
21. McFarlane Anderson N, Bennett FI, Alleyne GA. Ammonia production by the small intestine of the rat. Biochim Biophys Acta 1976; 437: 238-243
22. Jiang Q, Jiang XH, Zheng MH, Chen YP. L-Ornithine-laspartate in the management of hepatic encephalopathy: a meta-analysis. J Gastroenterol Hepatol 2009; 24: 9-14
23. Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 2009; 136: 2159-2168
24. Davies NA, Wright G, Ytrebø LM, Stadlbauer V, Fuskevåg OM, Zwingmann C, Davies DC, Habtesion A, Hodges SJ, Jalan R. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology 2009; 50: 155-164
25. Ytrebø LM, Kristiansen RG, Maehre H, Fuskevåg OM, Kalstad T, Revhaug A, Cobos MJ, Jalan R, Rose CF. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009; 50: 165-174
26. Jalan R, Wright G, Davies NA, Hodges SJ. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 2007; 69: 1064-1069